FACTX Mutual Fund

NAV$54.91
Showing 10 of 133 holdings(as of Jan 31, 2026)Top 10 Weight: 39.76%
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1BSXBoston Scientific Corp7.14%2,480,000$231.95M••••••••••••••••••••••
2LLYEli Lilly & Co6.45%202,000$209.50M••••••••••••••••••••••
3DHRDanaher Corp.6.25%928,000$203.13M••••••••••••••••••••••
4JNJJohnson & Johnson3.60%515,000$117.03M••••••••••••••••••••••
5NMFFidelity Securities Lending Cash Central Fund3.12%101,406,153$101.42M••••••••••••••••••••••
6ABBVAbbvie Inc3.02%440,000$98.12M••••••••••••••••••••••
7ARGX:ASArgenx Se Spon Adr Each Rep 1 Ord Shs2.82%109,000$91.61M••••••••••••••••••••••
8UCB:BRUcb Sa2.61%280,000$84.77M••••••••••••••••••••••
9ASND:COAscendis Pharma As Adr2.57%370,000$83.66M••••••••••••••••••••••
10CVSCvs Health Corp.2.18%950,000$70.79M••••••••••••••••••••••
Want to see all 133 holdings?View All HoldingsPRO

Top Holdings Themes

Medical DevicesCardiologyDigital HealthPharmaceuticalsBiotechnologyFood InnovationHealth & WellnessImmunologyLife Sciences ToolsBiotechnology ToolsUrbanizationInflation ProtectionSocial ImpactInfrastructureManaged Care

FACTX Mutual Fund Top Holdings

FACTX holdings top 10 positions. The top 10 holdings account for 39.8% of the fund, led by Boston Scientific Corp at 7.1%, Eli Lilly & Co at 6.5%, Danaher Corp. at 6.3%.

FACTX portfolio concentration is moderate, with the top 10 representing 39.8% of total assets. The largest sector exposure is Health Care at 86.1%.

FACTX sector allocation provides a detailed breakdown. FACTX overlap tool shows how holdings compare to other funds in your portfolio.